Small molecule immune oncology
Focusing on a novel immune-oncology target that is highly pursued by global pharmaceutical companies, we aim to maintain the lead position in pharmacology research and drug development. At the same time, we are expanding the indication into infectious diseases (antiviral) and strive to become the leading innovator in this field.




Address: 106 Fengze East Road, Nansha District, Guangzhou
Email: ming-med@ming-med.com
Copyright © 2020 ming-med.com 保留所有权利 粤ICP备20029450号-1